Amarin Corp plc | Home | Clinical Stage pharmaceutical Company
Amarin, Omega-3, hypertriglyceridemia, cardiovascular, AMR101, ultra pure EPA, lipid science - Amarin Amarin, cardiovascular, Omega-3, hypertriglyceridemia, dyslipidemia, lipid science, research, development, drugs, central nervous system, Miraxion, AMR101, myasthenia gravis, EN101, cardiovascular, triglyceride lowering, lipid, EPA, eicosapentaenoic acid, ethyl-EPA, Amarin is a clinical stage biopharmaceutical company with a lead program in Phase 3 for hypertriglyceridemia.
Related contacts of this company(?)